SOUTH SAN FRANCISCO, Calif., Aug. 16, 2022 /PRNewswire/ — Titan Prescribed drugs, Inc. (NASDAQ: TTNP) (“Titan” or the “Firm”) right now introduced that it has expanded its Board of Administrators (the “Board”) from 5 (5) to eleven (11) and appointed six new administrators following their election at its particular assembly of stockholders held on August 15, 2022 (the “Particular Assembly”). The brand new administrators, which have been on a nominee slate proposed by Activist Investing LLC (along with its associates, “Activist Investing”), are Avraham Ben-Tzvi, Peter L. Chasey, Eric Greenberg, David E. Lazar, Matthew C. McMurdo and David Natan.
As well as, following the Particular Assembly, Mr. Lazar was appointed interim Chairman and Chief Government Officer, with a mandate to guide Titan’s persevering with assessment of strategic alternate options. Mr. Lazar succeeds Marc Rubin, M.D., who will not function Government Chairman, however will stay on the Board.
“As one of many largest traders in Titan, Activist Investing’s purpose is to assist the Firm unlock worth for each ourselves and our fellow shareholders by means of a strategic transaction,” commented Mr. Lazar. “I consider the reconstituted Board, which collectively possess a long time of expertise in pharmaceutical govt management, medical analysis, strategic turnarounds, deal structuring, company governance, funding administration, accounting, finance and company legislation, might be an amazing asset on this endeavor.”
Biographies of Newly Elected Administrators
- Avraham Ben-Tzvi is the Founding father of ABZ Regulation Workplace, a boutique Israeli legislation agency specializing in outsourced normal counsel providers for publicly traded in addition to personal firms and companies, Investments & Securities Legal guidelines, Industrial Regulation & Contracts and varied civil legislation issues, which he established in January 2017. Mr. Ben-Tzvi served as Chief Authorized Officer and Normal Counsel of Purple Biotech Ltd. (previously Kitov Pharma Ltd.), a clinical-stage firm advancing first-in-class therapies to beat tumor immune evasion and drug resistance, from November 2015 till April 2020. Previous to that, Mr. Ben-Tzvi served as Normal Counsel and secretary at Medigus Ltd., a minimally invasive endosurgical instruments medical machine and miniaturized imaging gear firm, from April 2014 till November 2015. Mr. Ben-Tzvi is a member of the Israel Bar Affiliation, and can be licensed as a Notary by the Israeli Ministry of Justice. Previous to that he served as an lawyer at one in every of Israel’s main worldwide legislation corporations the place, amongst different company and industrial work, he suggested firms and underwriters on varied choices by Israeli firms itemizing in US and on varied SEC associated filings. Previous to turning into a lawyer, Mr. Ben-Tzvi labored in plenty of enterprise improvement, company finance and banking roles at firms within the monetary providers, lithium battery manufacturing and software program improvement industries. Mr. Ben-Tzvi holds a B.A., magna cum laude, in Economics from Yeshiva College in New York and an LLB, magna cum laude with Honors, in from Sha’arei Mishpat Faculty of Regulation in Hod HaSharon, Israel.
- Peter L. Chasey serves because the Proprietor of Chasey Regulation Workplaces, a legislation observe specializing in private litigation, enterprise litigation and industrial legislation, since founding the observe in 2005. Earlier in his profession, Mr. Chasey served as workers counsel for one of many largest insurance coverage firms on the earth defending normal claims in opposition to insured companies and in addition served as a land surveyor. Mr. Chasey holds a B.S. in Political Science and Authorities from the College of San Diego and a J.D. from the College of San Diego College of Regulation.
- Eric Greenberg has over 40 years of capital markets expertise. As a dealer and portfolio supervisor at hedge funds, his areas of experience included the event of buying and selling methods, portfolio administration and deal structuring. Mr. Greenberg was Co-Founding father of Blink Charging Co., a pacesetter within the EV charging infrastructure trade. As well as, Mr. Greenberg offers investor relation and digital advertising and marketing providers for firms throughout a wide range of industries, comparable to life sciences, fintech, web platforms and others. Mr. Greenberg holds a B.B.A in Finance from Baruch Faculty and an M.B.A. in Finance from Baruch Faculty Zicklin College of Enterprise.
- David E. Lazar has served because the Chief Government Officer of Custodian Ventures LLC, an organization which makes a speciality of aiding distressed public firms by means of custodianship, since February 2018, and Activist Investing LLC, an actively managed funding fund, since March 2018. Beforehand, Mr. Lazar served as Managing Accomplice at Zenith Companions Worldwide Inc., a boutique consulting agency, from July 2012 to April 2018. In his position as Chief Government Officer of Custodian Ventures LLC, Mr. Lazar has efficiently served as a custodian to quite a few public firms throughout a variety of industries. Mr. Lazar at the moment serves as an Advisor to PROMAX Investments LLC, a place he has held since July 2022, and as an Ambassador at Giant for the Arab African Council for Integration and Improvement, since March 2022.
- Matthew C. McMurdo at the moment serves as Managing Member of McMurdo Regulation Group, LLC, a company and securities legislation observe, since 2010. Beforehand, Mr. McMurdo was a Accomplice at Nannarone & McMurdo, LLP, a boutique legislation agency, from 2008 to 2010. As well as, Mr. McMurdo served as Normal Counsel of Berkley Asset Administration LLC, the final accomplice of an actual property fund centered on opportunistic and distressed actual property property, from 2011 to 2013. Mr. McMurdo holds a B.S. in Finance from Lehigh College and a J.D., cum laude, from Benjamin N. Cardozo College of Regulation.
- David Natan at the moment serves as President and Chief Government Officer of Natan & Associates, LLC, a consulting agency providing chief monetary officer providers to private and non-private firms in a wide range of industries, since 2007. As well as, Mr. Natan at the moment serves as Government Vice President and Chief Monetary Officer for Airborne Motorworks, Inc., a privately-held aerospace transportation firm, since April 2020. From February 2010 to Might 2020, Mr. Natan served as Chief Government Officer of ForceField Power, Inc., an organization centered on the photo voltaic trade and LED lighting merchandise. From February 2002 to November 2007, Mr. Natan served as Government Vice President of Reporting and Chief Monetary Officer of PharmaNet Improvement Group, Inc., a drug improvement providers firm, and, from June 1995 to February 2002, as Chief Monetary Officer and Vice President of World Technovations, Inc., a producer and marketer of oil evaluation devices and audio system and speaker parts. Previous to that, Mr. Natan served in varied roles of accelerating duty with Deloitte & Touche LLP, a world consulting agency. Mr. Natan at the moment serves as a member of the Board of Administrators and Chair of the Audit Committee of World Diversified Advertising and marketing Group, Inc., a producer, marketer and distributor of meals and snack merchandise, since February 2021 and serves as a member of the Board of Administrators and Chair of the Audit Committee of Sunshine Biopharma, Inc., a pharmaceutical and dietary complement firm, since February 2022. Beforehand, Mr. Natan served as Chairman of the Board of Administrators of ForceField Power, Inc., from April 2015 to Might 2020, and as a member of the Board of Administrators of World Technovations, Inc., from December 1999 to December 2001. Mr. Natan holds a B.A. in Economics from Boston College.
About Titan Prescribed drugs
Titan Prescribed drugs, Inc. (NASDAQ:TTNP), based mostly in South San Francisco, CA, is a improvement stage firm creating proprietary therapeutics with its ProNeura® long-term, steady drug supply know-how. The ProNeura know-how has the potential for use in creating merchandise for treating plenty of power situations, the place sustaining constant, around-the-clock blood ranges of medicine might profit the affected person and enhance medical outcomes. In December 2021, Titan commenced a course of to discover and consider strategic alternate options to boost shareholder worth.
For extra details about Titan, please go to www.titanpharm.com.
This press launch might comprise “forward-looking statements” inside the which means of Part 27A of the Securities Act of 1933 and Part 21E of the Securities Trade Act of 1934. Such statements embody, however will not be restricted to, any statements regarding our product improvement packages and some other statements that aren’t historic info. Such statements contain dangers and uncertainties that might negatively have an effect on our enterprise, working outcomes, monetary situation and inventory worth. Elements that might trigger precise outcomes to vary materially from administration’s present expectations embody these dangers and uncertainties regarding our capacity to boost capital, the regulatory approval course of, the event, testing, manufacturing and advertising and marketing of our drug candidates, patent and mental property issues and strategic agreements and relationships. We expressly disclaim any obligation or endeavor to launch publicly any updates or revisions to any forward-looking statements contained herein to replicate any change in our expectations or any adjustments in occasions, situations or circumstances on which any such assertion is predicated, besides as required by legislation.
David E. Lazar
SOURCE Titan Prescribed drugs, Inc.